Enzyme

Options are joining the wave of tokenized financial instruments.

As teams look beyond first-generation tokenized products, they’re starting to rebuild strategies directly onchain, using instruments like calls and puts to deploy capital with precision.

Enzyme.Myso is powering this shift:

• A $1.2M call on @aave was created and executed fully onchain
• @compoundfinance DAO deployed a covered call strategy targeting ~15% APY
• Treasuries and DAOs are using Enzyme.Myso to activate idle assets through custom options

This is how financial instruments scale onchain.

Learn more:

Organizations are bringing real-world assets onchain, and they need the right infrastructure to do it.

Enzyme delivers:
• Enzyme​.Blue → all-in-one vault platform
• Enzyme.Onyx → ultimate wallet tokenization layer

Learn more: https://enzyme.finance/use-cases/rwa

Summer in Cannes + DeFi, no better combo than this for sure. We are excited to announce that Enzyme goes to @EthCC [8] 🇫🇷

The biggest Web3 event in Europe is just around the corner, and we��re very excited to be in Paris with (almost) the whole team to enjoy the good conversations, good food, and the great energy.

We’re not just attending, we’re also bringing the energy with three curated side events designed to connect TradFi, DeFi, and the future of on-chain asset management. Here’s what we’ve got lined up:

🌅 Sea, DeFi & Sun - June 30
Join us in Cannes for a relaxed yet high-caliber brunch by the sea → https://t.co/Xcu8xFSGJw

🌇 Sunset & Assets - July 1
An exclusive evening on La Croisette with organized with our friends at @NexusMutual & @sygnumofficial. TradFi meets Web3 over curated conversations and sunset views → https://t.co/QPDiaBrAVg

🥐 Brunch by the Net - July 2
Enjoy the casual vibes with our partner @chain_security. Good food, sharp minds, and space to talk finance, infra, and what’s next → https://t.co/BxDs2vdx9H

We’ll be in town all week. Reach out if you want to meet, partner, or just talk programmable finance.

À bientôt!

Congratulations! You’ve decided to go onchain. Now what? What do institutions need to operate efficiently onchain? 1/6 🧵

Sygnum just joined the party ☀️🍸

We’re co-hosting Sunset & Assets with @sygnumofficial and @NexusMutual during @EthCC!

📍 La Croisette, Cannes
📅 July 1, 7:30 PM
🥂 Open bar, curated crowd, real conversations

Spots are limited → https://lu.ma/in5916cw

Right now, everyone talks about tokenized funds, but there are two very different ways to build them.

The first, and most common today, is ad-hoc tokenization: wrapping existing offchain funds into an onchain wrapper via RWA platforms. The second is building natively tokenized funds: programmable, composable, and fully onchain from day one. Innovative businesses are already anticipating this next wave.

Enzyme supports both models. Understand the difference ↓

The question is no longer if tokenized funds will scale, it’s how far they’ll go.

According to @Citi, tokenized securities could grow into a $4–5T market by 2030. The World Economic Forum (@wef) estimates that 10% of global GDP could be tokenized and stored on the blockchain by 2027.

As we look toward the next decade, the financial system is undergoing a structural rewrite.

Since traditional funds face pressure from outdated infrastructure and rising operational costs, tokenized vehicles offer an alternative that’s programmable, composable, and globally accessible. From ETFs and term deposits to structured products and debt instruments, financial logic is moving onchain.

In the next cycle, we expect to see:
• A big shift towards natively tokenized funds rather than tokenization of existing layers
• More institutional experimentation with onchain funds
• A new generation of asset managers building directly into DeFi infrastructure
• Policy shifts enabling greater clarity and adoption of onchain vehicles

Enzyme is built to support this shift with the flexibility to design tokenized strategies natively or bring existing products onchain.

Explore the infrastructure behind tomorrow’s fund models → 

The question is no longer if tokenized funds will scale, it’s how far they’ll go.

According to @Citi, tokenized securities could grow into a $4–5T market by 2030. The World Economic Forum (@wef) estimates that 10% of global GDP could be tokenized and stored on the blockchain by 2027.

As we look toward the next decade, the financial system is undergoing a structural rewrite.

Since traditional funds face pressure from outdated infrastructure and rising operational costs, tokenized vehicles offer an alternative that’s programmable, composable, and globally accessible. From ETFs and term deposits to structured products and debt instruments, financial logic is moving onchain.

In the next cycle, we expect to see:
• A big shift towards natively tokenized funds rather then tokenization of existing layers
• More institutional experimentation with onchain funds
• A new generation of asset managers building directly into DeFi infrastructure
• Policy shifts enabling greater clarity and adoption of onchain vehicles

Enzyme is built to support this shift with the flexibility to design tokenized strategies natively or bring existing products onchain.

Explore the infrastructure behind tomorrow’s fund models → 

Congratulations to our friends at @Chainlink on powering Hong Kong’s recent CBDC and stablecoin pilot 👏

This is the kind of trusted infrastructure that connects traditional banking with blockchain-based asset tokenization.

Great to see Chainlink driving tangible progress 🤝

Enzyme won Blockchain Tech of the Year Award at @Hedgeweek Digital Assets Awards 2025 🏆

Proud to be recognized for building real tokenized finance infrastructure, alongside great nominees like @inside_r3, @talostrading, and more.

Thanks to HedgeWeek for a great summit! 🤝

Enzyme won Blockchain Tech of the Year Award at @Hedgeweek Digital Assets Awards 2025 🏆

Proud to be recognized for building real tokenized finance infrastructure, alongside great nominees like @inside_r3, @talostrading, Triangle Digital, & SWIAT.

Thanks to HedgeWeek for a great summit! 🤝

According to a recent report from @binance, the RWA tokenization market has experienced a remarkable 260% growth in the first half of 2025, reaching a valuation of $23 billion. 📈

This surge is largely attributed to increasing regulatory clarity in the industry, which has encouraged firms to embrace regulated crypto frameworks.

At Enzyme, we’re witnessing this momentum firsthand. Our solutions enable users to manage tokenized assets within customizable vaults, facilitating strategies that leverage RWAs effectively.

Explore how Enzyme can support your RWA strategies: 

RWAs are the bridge between traditional capital and DeFi strategy. Vaults are how you cross it.

On Enzyme, RWAs can be deposited into customizable vaults, unlocking new ways to manage, monitor, and interact with tokenized capital.

With Enzyme, you can:

- Build and distribute financial instruments with RWA exposure without the operational overhead.
- Pool RWAs within a dedicated liquidity vehicle or raise capital for RWA strategies with built-in incentive mechanisms.
- Integrate tokenized Treasury Bills, stocks, bonds, real estate, and more into your fund strategy.

Enzyme gives financial builders the tools to move from tokenization to activation, turning static representations into live, operational components of a fund or strategy.

Learn more: 

How are real-world assets tokenized?

Here’s a quick breakdown, from legal structuring to onchain deployment👇 1/🧵

The SEC clarified: some PoS staking activities, when structured right, don’t count as securities transactions.

Clarity matters, especially as staking becomes core to institutional tokenized strategies.

Enzyme powers staking activities with its infrastructure. 👇

Boost your staking activity with Enzyme 🧬

Design yield-generating products, and drive liquidity for your LSTs & LRTs all in one place.

Explore what’s possible: http://enzyme.finance/actors/staking?utm_source=x&utm_medium=organic&utm_content=post

Want to create natively tokenized funds?

→ Use Enzyme​.Blue to build and manage natively tokenized products
→ Use Enzyme.Onyx to deploy an Enzyme Vault on top of any existing wallet
→ Use Enzyme.Myso to integrate options into fund strategies

Everything onchain. 1/🧵

Enzyme.Myso v3 just passed $16M in total notional volume. 📈

Launched earlier this year, the protocol is powering covered calls and cash-secured puts at scale, most recently a $1.2M call on $AAVE.

It’ll only get bigger from here. Learn more → https://enzyme.finance/products/myso?utm_source=x&utm_medium=organic&utm_content=post

DAOs are learning: capital preservation ≠ capital stagnation

@compoundfinance DAO is proving it by using Enzyme.Myso to put covered calls into their treasury management strategy, targeting 15% APY without compromising security.

Try the premier protocol for onchain options: 

Tokenization without execution infrastructure is just window dressing. Change our mind 🤷